Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 181,270 | 192,844 | 90,332 | 59,110 | 83,715 |
| Receivables | 18,329 | 13,658 | 6,021 | 13,265 | 7,058 |
| Inventories | 11,096 | 7,767 | 7,137 | 7,437 | 7,099 |
| Other current assets | 0 | 0 | 14,281 | 0 | 0 |
| TOTAL | $215,881 | $216,780 | $120,482 | $82,202 | $101,464 |
| Non-Current Assets | |||||
| PPE Net | 7,095 | 7,144 | 2,764 | 7,793 | 6,284 |
| Intangibles | 2,570 | 2,544 | 3,519 | 14,839 | 224 |
| Other Non-Current Assets | 9,706 | 5,652 | 17,471 | 19,178 | 1,880 |
| TOTAL | $19,371 | $15,340 | $23,754 | $41,810 | $8,388 |
| Total Assets | $235,252 | $232,120 | $144,236 | $124,012 | $109,852 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,420 | 2,886 | 5,630 | 3,285 | 3,878 |
| Accrued Expenses | 10,396 | 10,891 | 7,807 | 14,282 | 9,949 |
| Other current liabilities | N/A | 4,106 | 8,972 | 882 | N/A |
| TOTAL | $13,819 | $18,008 | $22,445 | $18,490 | $15,481 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32 | 106 | 29,856 | 29,601 | 386 |
| Deferred Revenues | 19 | 125 | 36 | 41 | 1,654 |
| Other Non-Current Liabilities | 7,710 | 0 | 4,306 | 2,957 | 1,293 |
| TOTAL | $7,742 | $106 | $34,162 | $32,558 | $1,679 |
| Total Liabilities | $21,561 | $18,114 | $56,607 | $51,048 | $17,160 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,205 | 26,617 | 25,872 | 22,712 | 22,566 |
| Common Shares | 276 | 276 | 269 | 243 | 243 |
| Retained earnings | -84,033 | -80,762 | -201,541 | -168,656 | -146,307 |
| Other shareholders' equity | -7,461 | -8,523 | -5,712 | -7,751 | -5,277 |
| TOTAL | $213,691 | $214,006 | $87,629 | $72,964 | $92,692 |
| Total Liabilities And Equity | $235,252 | $232,120 | $144,236 | $124,012 | $109,852 |